Removal of periocular veins by sclerotherapy

Research output: Contribution to journalArticle

Abstract

Purpose: Prominent periocular veins, especially of the lower eyelid, are not uncommon and patients often seek their removal. Sclerotherapy is a procedure that has been successfully used to permanently remove varicose and telangiectatic veins of the lower extremity and less frequently at other sites. Although it has been successfully used to remove dilated facial veins, it is seldom performed and often not recommended in the periocular region for fear of complications occurring in adjacent structures. The purpose of this study was to determine whether sclerotherapy could safely and effectively eradicate prominent periocular veins. Design: Noncomparative case series. Participants: Fifty adult female patients with prominent periocular veins in the lower eyelid were treated unilaterally. Patients and Methods: Sclerotherapy was performed with a 0.75% solution of sodium tetradecyl sulfate. All patients were followed for at least 12 months after treatment. Main Outcome Measures: Complete clinical disappearance of the treated vein was the criterion for success. Results: All 50 patients were successfully treated with uneventful resorption of their ectatic periocular veins. No patient required a second treatment and there was no evidence of treatment failure at 12 months. No new veins developed at the treated sites and no patient experienced any ophthalmologic or neurologic side effects or complications. Conclusions: Sclerotherapy appears to be a safe and effective means of permanently eradicating periocular veins.

Original languageEnglish (US)
Pages (from-to)442-448
Number of pages7
JournalOphthalmology
Volume108
Issue number3
DOIs
StatePublished - Mar 10 2001
Externally publishedYes

Fingerprint

Sclerotherapy
Veins
Eyelids
Sodium Tetradecyl Sulfate
Varicose Veins
Treatment Failure
Nervous System
Fear
Lower Extremity
Outcome Assessment (Health Care)
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Removal of periocular veins by sclerotherapy. / Green, David.

In: Ophthalmology, Vol. 108, No. 3, 10.03.2001, p. 442-448.

Research output: Contribution to journalArticle

Green, David. / Removal of periocular veins by sclerotherapy. In: Ophthalmology. 2001 ; Vol. 108, No. 3. pp. 442-448.
@article{4e07ad6ae52f467a8ec3df05bd7f280e,
title = "Removal of periocular veins by sclerotherapy",
abstract = "Purpose: Prominent periocular veins, especially of the lower eyelid, are not uncommon and patients often seek their removal. Sclerotherapy is a procedure that has been successfully used to permanently remove varicose and telangiectatic veins of the lower extremity and less frequently at other sites. Although it has been successfully used to remove dilated facial veins, it is seldom performed and often not recommended in the periocular region for fear of complications occurring in adjacent structures. The purpose of this study was to determine whether sclerotherapy could safely and effectively eradicate prominent periocular veins. Design: Noncomparative case series. Participants: Fifty adult female patients with prominent periocular veins in the lower eyelid were treated unilaterally. Patients and Methods: Sclerotherapy was performed with a 0.75{\%} solution of sodium tetradecyl sulfate. All patients were followed for at least 12 months after treatment. Main Outcome Measures: Complete clinical disappearance of the treated vein was the criterion for success. Results: All 50 patients were successfully treated with uneventful resorption of their ectatic periocular veins. No patient required a second treatment and there was no evidence of treatment failure at 12 months. No new veins developed at the treated sites and no patient experienced any ophthalmologic or neurologic side effects or complications. Conclusions: Sclerotherapy appears to be a safe and effective means of permanently eradicating periocular veins.",
author = "David Green",
year = "2001",
month = "3",
day = "10",
doi = "10.1016/S0161-6420(00)00384-5",
language = "English (US)",
volume = "108",
pages = "442--448",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Removal of periocular veins by sclerotherapy

AU - Green, David

PY - 2001/3/10

Y1 - 2001/3/10

N2 - Purpose: Prominent periocular veins, especially of the lower eyelid, are not uncommon and patients often seek their removal. Sclerotherapy is a procedure that has been successfully used to permanently remove varicose and telangiectatic veins of the lower extremity and less frequently at other sites. Although it has been successfully used to remove dilated facial veins, it is seldom performed and often not recommended in the periocular region for fear of complications occurring in adjacent structures. The purpose of this study was to determine whether sclerotherapy could safely and effectively eradicate prominent periocular veins. Design: Noncomparative case series. Participants: Fifty adult female patients with prominent periocular veins in the lower eyelid were treated unilaterally. Patients and Methods: Sclerotherapy was performed with a 0.75% solution of sodium tetradecyl sulfate. All patients were followed for at least 12 months after treatment. Main Outcome Measures: Complete clinical disappearance of the treated vein was the criterion for success. Results: All 50 patients were successfully treated with uneventful resorption of their ectatic periocular veins. No patient required a second treatment and there was no evidence of treatment failure at 12 months. No new veins developed at the treated sites and no patient experienced any ophthalmologic or neurologic side effects or complications. Conclusions: Sclerotherapy appears to be a safe and effective means of permanently eradicating periocular veins.

AB - Purpose: Prominent periocular veins, especially of the lower eyelid, are not uncommon and patients often seek their removal. Sclerotherapy is a procedure that has been successfully used to permanently remove varicose and telangiectatic veins of the lower extremity and less frequently at other sites. Although it has been successfully used to remove dilated facial veins, it is seldom performed and often not recommended in the periocular region for fear of complications occurring in adjacent structures. The purpose of this study was to determine whether sclerotherapy could safely and effectively eradicate prominent periocular veins. Design: Noncomparative case series. Participants: Fifty adult female patients with prominent periocular veins in the lower eyelid were treated unilaterally. Patients and Methods: Sclerotherapy was performed with a 0.75% solution of sodium tetradecyl sulfate. All patients were followed for at least 12 months after treatment. Main Outcome Measures: Complete clinical disappearance of the treated vein was the criterion for success. Results: All 50 patients were successfully treated with uneventful resorption of their ectatic periocular veins. No patient required a second treatment and there was no evidence of treatment failure at 12 months. No new veins developed at the treated sites and no patient experienced any ophthalmologic or neurologic side effects or complications. Conclusions: Sclerotherapy appears to be a safe and effective means of permanently eradicating periocular veins.

UR - http://www.scopus.com/inward/record.url?scp=0035118670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035118670&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(00)00384-5

DO - 10.1016/S0161-6420(00)00384-5

M3 - Article

C2 - 11237897

AN - SCOPUS:0035118670

VL - 108

SP - 442

EP - 448

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 3

ER -